Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02357121 | Focal Laser Ablation of Prostate Tissue(FLA) | completed | Early Phase 1 | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT00727948 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | completed | Early Phase 1 | 11 | University of VermontOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT01875666 | Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib | completed | Early Phase 1 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT01467310 | Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 | completed | Early Phase 1 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT02900469 | Presurgical Trial of Denosumab in Breast Cancer | completed | Early Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT02744729 | 99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients | completed | Early Phase 1 | 29 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00949247 | Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases | completed | Early Phase 1 | 20 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT02352025 | S-equol in Women With Triple Negative Breast Cancer | completed | Early Phase 1 | 39 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01823991 | COGNUTRIN in Breast Cancer Survivors | completed | Early Phase 1 | 36 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT00510367 | Primary Breast Cancer Occurring Concomitant With Pregnancy | completed | Early Phase 1 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT02927626 | Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma(YYFZTIHBVHCC) | completed | Early Phase 1 | 132 | Beijing Ditan HospitalOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT04461457 | Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2 | completed | Early Phase 1 | 12 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 8, 2020 | clinicaltrials |
| NCT02767362 | A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium | completed | Early Phase 1 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03197012 | Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor | completed | Early Phase 1 | 10 | Thomas HopeOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02153450 | Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer | completed | Early Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT04440956 | An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours | completed | Early Phase 1 | 10 | Clarity Pharmaceuticals LtdINDUSTRY | 0 | Jun 22, 2020 | clinicaltrials |
| NCT02802098 | Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer | completed | Early Phase 1 | 25 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT01880749 | Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas | completed | Early Phase 1 | 5 | NYU Langone HealthOTHER | 1 | May 13, 2020 | clinicaltrials |
| NCT01359267 | Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer | completed | Early Phase 1 | 12 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02331706 | IFN-DLI for Relapsed Acute Leukemia After Allo-SCT | completed | Early Phase 1 | 16 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT03224871 | UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC. | completed | Early Phase 1 | 3 | University of California, DavisOTHER | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03004534 | A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide | completed | Early Phase 1 | 36 | Translational Research in OncologyOTHER | 3 | Apr 3, 2020 | clinicaltrials |
| NCT01221506 | Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) | completed | Early Phase 1 | 20 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04321161 | Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment | completed | Early Phase 1 | 10 | University of FreiburgOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03592121 | Study to Investigate the Effect of AB-101 in Breast Cancer Survivors | completed | Early Phase 1 | 3 | Applied Biology, Inc.INDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04289532 | Integrin α6-targeted SPECT Imaging of Breast Cancer | completed | Early Phase 1 | 9 | Peking UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04296266 | Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery | completed | Early Phase 1 | 10 | Stanford UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT01670799 | Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer | completed | Early Phase 1 | 29 | New Mexico Cancer Research AllianceOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT01380353 | Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | completed | Early Phase 1 | 103 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02604862 | Imaging FIB ONE in the Human Lung Using Endomicroscopy(FIB ONE) | completed | Early Phase 1 | 18 | University of EdinburghOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04145323 | Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients | completed | Early Phase 1 | 10 | University of Wisconsin, MadisonOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01239875 | Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma | completed | Early Phase 1 | 16 | Mayo ClinicOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT02320305 | MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery | completed | Early Phase 1 | 23 | Mayo ClinicOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT00013533 | Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | completed | Early Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00339469 | Effect of High-Legume Diet on Colorectal Cancer Risk | completed | Early Phase 1 | 65 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00993057 | Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia | completed | Early Phase 1 | 120 | Northwestern UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | completed | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01263613 | Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer | completed | Early Phase 1 | 6 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT02316795 | Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | completed | Early Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04056026 | A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma | completed | Early Phase 1 | 1 | ProgenaBiomeOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT01730729 | Cabergoline in Metastatic Breast Cancer | completed | Early Phase 1 | 20 | Northwestern UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02628080 | Atovaquone as Tumour HypOxia Modifier(ATOM) | completed | Early Phase 1 | 46 | University of OxfordOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT04017845 | Screening for Colorectal Cancer in Average and High Risk Population | completed | Early Phase 1 | 537 | Lewai Sharki Abdulaziz, MSc PhDOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT00795457 | Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas | completed | Early Phase 1 | 13 | Ian F. Pollack, M.D.OTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01504126 | Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Early Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 29, 2019 | clinicaltrials |
| NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT(GCC 1324) | completed | Early Phase 1 | 8 | University of Maryland, BaltimoreOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT01722149 | Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma | completed | Early Phase 1 | 4 | University of ZurichOTHER | 1 | Aug 7, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Sep 21, 2020source: clinicaltrials